The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family ...

Bankrupt Purdue Pharma LP and its owners have agreed to over $7 billion settlement to resolve lawsuits over OxyContin's role ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Purdue Pharma and the Sackler family reach a $7.4 billion settlement over their role in the US opioid crisis. The deal, increasing the previous offer by $1.4 billion, ends Sackler control of Purdue ...

This settlement is among the largest in recent years as lawsuits seek to hold companies accountable for the US opioid epidemic.

The U.S. Food and Drug Administration (“FDA”), in partnership with the Department of Justice (“DOJ”), pursued significant and, in some ...

The New York Times reports that the tentative $7.4 billion agreement with 15 states would also require those states to set aside as much as $800 million in what amounts to a legal defense fund for the ...

A federal grand jury charged seven people with running a multi-state conspiracy attempting to defraud the United States for ...

Varadkar has been named as the Hauser Leader of the Harvard Kennedy School Center for Public Leadership for its spring ...

Endo's slide into bankruptcy follows in the footsteps of Purdue Pharma – which filed in 2019 ... to two Ohio counties in the wake of a jury trial, which found them culpable of fuelling the ...

The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would end ...

Jan. 23 (UPI) --The Sackler family and Purdue Pharma have agreed to pay a $7.4 billion settlement to end federal court claims filed by attorneys general on behalf of 15 states. New York Attorney ...